期刊文献+

骨化三醇冲击治疗尿毒症继发性甲状旁腺功能亢进的效果分析 被引量:2

The effect analysis of calcitriol impulse therapy in the treatment of uremia secondary hyperparathyroidism
下载PDF
导出
摘要 目的分析骨化三醇冲击治疗尿毒症继发性甲状旁腺功能亢进的疗效。方法将2011年2月~2013年1月本院尿毒症继发性甲状旁腺功能亢进患者83例纳入研究,根据患者意愿分为A、B组,均接受低钙透析治疗,在此基础上A组患者接受骨化三醇常规治疗,B组患者接受骨化三醇冲击治疗。连续治疗8周,对比两组患者血清钙(Ca)、磷(P)和甲状旁腺激素(PTH)指标和不良反应的差异性。结果与A组比较,B组患者血清Ca、P、PTH水平较低,不良反应发生率较低,差异有统计学意义(P<0.05)。结论采用骨化三醇冲击治疗尿毒症继发性甲状旁腺功能亢进的疗效和安全性具有一定的优越性,值得临床推广应用。 Objective To analyze the effect of calcitriol impulse therapy in the treatment of uremia secondary hyper- parathyroidism.Methods 83 uremia patients with secondary hyperparathyroidism in our hospital collected from Febru- ary 2011 to January 2013 were divided into group A and group B according to their own wills.All patients were treated with low calcium dialysis,on the basis of which,group A received conventional calcitriol therapy,and group B received ealcitriol impulse therapy.All patients were treated continuously for 8 weeks;the indexes of serum calcium (Ca),phos- phorus (P),parathyroid hormone (PTH),and the difference of adverse reactions were compared with each group.Results Compared with group A,the levels of serum Ca,P,PTH and the rate of adverse reaction in group B were much lower, with significant difference (P〈0.05).Condusion Calcitriol impulse therapy has certain efficacy and safety in the treat- ment of uremia secondary hyperparathyroidism,and it deserves applying extends.
作者 黄平
出处 《中国当代医药》 2013年第27期78-79,共2页 China Modern Medicine
关键词 骨化三醇 冲击疗法 尿毒症 继发性甲状旁腺功能亢进 Calcitriol Impulse therapy Uremia Secondary hyperparathyroidism
  • 相关文献

参考文献6

二级参考文献33

  • 1邱维强.肾性骨病诊断与治疗研究进展[J].临床荟萃,2001,16(1):33-34. 被引量:33
  • 2黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 3Lai KN,Ho K,Cheang RC,et al.Effect of low mole-cular weight heparin on bone metabolism and hyperli-pidemia in patienla on maintenance hemodialysis[J].Int J Artif Organs,2001,24:447-455.
  • 4Lein NW,Hulberg-shearon TE,Strawderman RL,et al.Which causes of death are related to Hyperpho-sphatemin in hemodialyiss patients[J].J Am Soc Nephrol,1998,9:217.
  • 5王梅主译.牛津临床透析手册[M].2版.北京:人民卫生出版社,2006:20.
  • 6Swaya BP, Koszewski N J, Qi Q, et al. Secondary hyperparathyroidism and vitamin D recepor binding to vitamin D response elements in rats with incipient renal failure [J]. J Am Soc Nephrol, 1997, 9: 1324-1330.
  • 7Lach F, Yudd M. Pathogenic clinical and therapeutic aspects of seeondary hyperparathyroidism in chronic renal failure [J]. Am J Kidney, 32(Suppl 2): 3-9.
  • 8Tsukamoto Y, Namara M, Takahaslai Y, et al. The oral 1,25-dihydroxyvitamin D3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism [J]. Nephrol, 1991, 57:23 -28.
  • 9Rapopart J, Marcus M, Ahron B, et al. Successful Ireatment of SHPT in hemodialysis patients with puls 1-alpha-hydroxycholecalciferol therapy [J]. Nephrol, 1996, 72: 150-154.
  • 10Modified from Macdougall LC. Nephrol Dial Transplant, 2000,15(Suppl 3) :3 - 7.

共引文献55

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部